Volume 27, Number 9—September 2021
Research
Spatiotemporal Dynamics of Sporadic Shiga Toxin–Producing Escherichia coli Enteritis, Ireland, 2013–2017
Eimear Cleary1, Martin Boudou1, Patricia Garvey, Coilin Oh Aiseadha, Paul McKeown, Jean O’Dwyer
, and Paul Hynds
, and Paul Hynds
Table 1
Confirmed sporadic verocytotoxin-producing Escherichia coli infections in Ireland, 2013–2017*
| Characteristic | VTEC O157 | VTEC 026 | Other serogroups | Not serotyped/ungroupable |
|---|---|---|---|---|
| Total |
668 |
714 |
724 |
649 |
| Age | ||||
| <5 y | 231 (34.6) | 431 (60.4) | 255 (35.2) | 184 (28.4) |
| 6–64 y | 373 (55.8) | 232 (32.5) | 314 (43.4) | 273 (42.1) |
| >65 y |
64 (9.6) |
51 (7.1) |
155 (21.4) |
192 (29.6) |
| Setting | ||||
| Urban | 288 (43.1) | 278 (38.9) | 329 (45.4) | 309 (47.6) |
| Rural | 380 (56.9) | 436 (61.1) | 395 (54.6) | 340 (52.4) |
*Values are no. (%) except as indicated. Percentages refer to VTEC serotype column totals vs case age range and Central Statistics Office Urban/Rural classification. VTEC, verocytotoxin-producing Escherichia coli.
1These first authors contributed equally to this article.
Page created: July 15, 2021
Page updated: August 17, 2021
Page reviewed: August 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential